Correlation Between Xilio Development and Werewolf Therapeutics
Can any of the company-specific risk be diversified away by investing in both Xilio Development and Werewolf Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Xilio Development and Werewolf Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Xilio Development and Werewolf Therapeutics, you can compare the effects of market volatilities on Xilio Development and Werewolf Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Xilio Development with a short position of Werewolf Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Xilio Development and Werewolf Therapeutics.
Diversification Opportunities for Xilio Development and Werewolf Therapeutics
0.25 | Correlation Coefficient |
Modest diversification
The 3 months correlation between Xilio and Werewolf is 0.25. Overlapping area represents the amount of risk that can be diversified away by holding Xilio Development and Werewolf Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Werewolf Therapeutics and Xilio Development is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Xilio Development are associated (or correlated) with Werewolf Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Werewolf Therapeutics has no effect on the direction of Xilio Development i.e., Xilio Development and Werewolf Therapeutics go up and down completely randomly.
Pair Corralation between Xilio Development and Werewolf Therapeutics
Considering the 90-day investment horizon Xilio Development is expected to generate 4.55 times less return on investment than Werewolf Therapeutics. But when comparing it to its historical volatility, Xilio Development is 1.03 times less risky than Werewolf Therapeutics. It trades about 0.01 of its potential returns per unit of risk. Werewolf Therapeutics is currently generating about 0.03 of returns per unit of risk over similar time horizon. If you would invest 205.00 in Werewolf Therapeutics on September 3, 2024 and sell it today you would lose (9.00) from holding Werewolf Therapeutics or give up 4.39% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Very Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Xilio Development vs. Werewolf Therapeutics
Performance |
| Timeline |
| Xilio Development |
| Werewolf Therapeutics |
Xilio Development and Werewolf Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Xilio Development and Werewolf Therapeutics
The main advantage of trading using opposite Xilio Development and Werewolf Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Xilio Development position performs unexpectedly, Werewolf Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Werewolf Therapeutics will offset losses from the drop in Werewolf Therapeutics' long position.| Xilio Development vs. DiaMedica Therapeutics | Xilio Development vs. Lyra Therapeutics | Xilio Development vs. Centessa Pharmaceuticals PLC |
| Werewolf Therapeutics vs. Monte Rosa Therapeutics | Werewolf Therapeutics vs. Design Therapeutics | Werewolf Therapeutics vs. Ikena Oncology | Werewolf Therapeutics vs. Stoke Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Equity Search module to search for actively traded equities including funds and ETFs from over 30 global markets.
Other Complementary Tools
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA |